Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors
- 8 December 2011
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 91 (6) , 897-904
Abstract
Although hemophagocytic syndrome (HS) featuring secondary hemophagocytic lymphohistiocytosis (HLH) has a grave prognosis, little is known about the natural course of the disease. Patients who showed the clinical features of HLH as well as tissue-proven hemophagocytosis when seen at Asan Medical Center between 1999 and 2010 were included in this analysis. Patients with proven lymphoma were excluded. The median age of our 23 study patients was 49 years. Epstein–Barr virus was suspected to have caused HS in 16 (70%) patients and hepatitis A virus in one patient. Twenty-two patients were treated, 13 according to the HLH protocol and nine using immunosuppressive agents such as corticosteroid and/or cyclosporine. Five patients undertook allogeneic hematopoietic cell transplantation (HCT) during their treatment-dependent relapse (n = 4) or responsive status (n = 1). After the median follow-up of 180 days, 17 (74%) died and six (26%) were alive. The median time from initial presentation until death was 41 days among those patients who died. The serum fibrinogen level ≥166 mg/dL determined at the initial visit was significantly associated with the survival time according to univariate analysis. The low histiocyte proportion in bone marrow and early initiation of treatment tended to correlate with a favorable outcome. On multivariate analysis, serum fibrinogen ≥166 mg/dL (hazard ratio, 0.175, P = 0.018) was an independent clinical factor for determining the patient survival time. Despite appropriate patient management, the outcome of HS featuring HLH was grave. The serum fibrinogen level at the initial presentation was significant, and selected patients obtained some benefit from allogeneic HCT.Keywords
This publication has 23 references indexed in Scilit:
- Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortalityPediatric Blood & Cancer, 2010
- Clinical significance of clonality and Epstein‐Barr virus infection in adult patients with hemophagocytic lymphohistiocytosisAmerican Journal of Hematology, 2010
- Severe Epstein-Barr Virus Encephalitis With Hemophagocytic SyndromeThe Pediatric Infectious Disease Journal, 2010
- Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in JapanPediatric Blood & Cancer, 2009
- Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 casesRheumatology, 2008
- Poor Outcomes of Chronic Active Epstein‐Barr Virus Infection and Hemophagocytic Lymphohistiocytosis in Non‐Japanese Adult PatientsClinical Infectious Diseases, 2008
- Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disease in JapanAmerican Journal of Hematology, 2008
- Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosisBritish Journal of Haematology, 2007
- Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: A report from the HLH studyl centerMedical and Pediatric Oncology, 2003
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999